LEARN MORE
Spravato® (esketamine nasal spray) is the first and only FDA-approved nasal spray for adults with treatment-resistant depression (TRD).
Spravato® works differently than traditional antidepressants by targeting glutamate pathways in the brain to help improve mood and relieve symptoms when other medications haven’t worked.
You self-administer the nasal spray under direct medical supervision in our comfortable, private treatment room.
You'll stay and relax for about 2 hours while our care team monitors you for any side effects.
A trusted family member or caregiver will need to drive you home afterward.
We are fully REMS-certified to administer Spravato® in compliance with FDA safety standards.
Most major insurance plans, including Medicaid, are accepted for Spravato® treatment.
Our caring team ensures your comfort, privacy, and well-being at every step of treatment.
IS SPRAVATO® RIGHT FOR YOU?
Spravato® is not for everyone — certain health conditions or a history of substance misuse may mean it’s not the right fit. Our care team will review your full medical history to ensure your safety.
Spravato® contains esketamine, which is chemically related to ketamine, but it’s given as a nasal spray in a safe, controlled setting.
No. You’ll need someone to drive you home after each session for safety.
Your doctor will create a personalized plan. Most patients start with twice-weekly sessions, then taper down over time.
Yes, Spravato® is covered by most insurance plans. Our team will help verify your benefits and guide you through approval.
